Huntington Disease [clinicaltrials_resource:2ecd31de9e351001768dac1759857e52]
clinicaltrials:NCT00051324Prospective Huntington At Risk Observational Study [clinicaltrials:NCT00052143]Family Health After Predictive Huntington Disease (HD) Testing [clinicaltrials:NCT00075140]TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease [clinicaltrials:NCT00146211]clinicaltrials:NCT00190450clinicaltrials:NCT00271596clinicaltrials:NCT00277355Riluzole in Huntington's Disease [clinicaltrials:NCT00277602]Cooperative Huntington's Observational Research Trial [clinicaltrials:NCT00313495]clinicaltrials:NCT00368849Research of Biomarkers in Parkinson Disease [clinicaltrials:NCT00465790]clinicaltrials:NCT00514774Making Sense of a Positive Genetic Test Result for Huntington Disease [clinicaltrials:NCT00539747]clinicaltrials:NCT00592995clinicaltrials:NCT00632645Memory Disorders Registry [clinicaltrials:NCT00654563]Far Infrared Irradiation for Managing, Control and Treatment of Huntington's Disease (HD) [clinicaltrials:NCT00675077]A Study of ACR16 for the Treatment of Patients With Huntington's Disease [clinicaltrials:NCT00724048]A Phase 1 Study To Evaluate The Effect Of Dimebon On The Pharmacokinetics Of Dextromethorphan [clinicaltrials:NCT00788047]clinicaltrials:NCT00831506A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions [clinicaltrials:NCT00870974]A Safety and Efficacy Study of Dimebon in Patients With Huntington Disease [clinicaltrials:NCT00920946]Evaluation of [123I]MNI-420 and SPECT as a Marker of the Adenosine A2a Receptor in PD, HD and Healthy Subjects. [clinicaltrials:NCT00970229]Bioavailability of Ubiquinol in Huntington Disease [clinicaltrials:NCT00980694]A Study In Healthy Volunteers To Estimate The Pharmacokinetics Of Four Modified-Release Formulations Of Dimebon (Latrepirdine) [clinicaltrials:NCT00988624]An Extension of the HORIZON Protocol Evaluating the Safety of Dimebon (Latrepirdine) in Subjects With Huntington Disease [clinicaltrials:NCT01085266]Open-label Extension Study of Pridopidine (ACR16) in the Symptomatic Treatment of Huntington Disease [clinicaltrials:NCT01306929]clinicaltrials:NCT01339130Effects of EGCG (Epigallocatechin Gallate) in Huntington's Disease (ETON-Study) [clinicaltrials:NCT01357681]31P-MRS and Huntington Disease [clinicaltrials:NCT01359774]clinicaltrials:NCT01412125clinicaltrials:NCT01458470Study of Huntington Patients in Connection With European Huntington's Disease Network (EHDN) [clinicaltrials:NCT01554033]clinicaltrials:NCT01590589Effect of PBT2 in Patients With Early to Mid Stage Huntington Disease [clinicaltrials:NCT01590888]Healthy Volunteer Positron Emission Tomography (PET) Brain Occupancy Study of a Phosphodiesterase 4 (PDE4) Inhibitor in Huntington's Disease [clinicaltrials:NCT01602900]Utilization of 31P-Nuclear Magnetic Resonance Spectroscopy to Monitor Brain Energy Deficit in Huntington Disease [clinicaltrials:NCT01696708]clinicaltrials:NCT01834053Effect of Tetrabenazine on Stroop Interference in HD [clinicaltrials:NCT01834911]Dance and Huntington Disease [clinicaltrials:NCT01842919]
condition [clinicaltrials_vocabulary:condition]
Treatment of Huntington's Chorea With Amantadine [clinicaltrials:NCT00001930]Long-Term Study of Cerebral Glucose Metabolism in Huntington's Disease [clinicaltrials:NCT00004753]Creatine Therapy for Huntington's Disease [clinicaltrials:NCT00026988]Minocycline in Patients With Huntington's Disease [clinicaltrials:NCT00029874]clinicaltrials:NCT00051324Prospective Huntington At Risk Observational Study [clinicaltrials:NCT00052143]Family Health After Predictive Huntington Disease (HD) Testing [clinicaltrials:NCT00075140]Effects of Lithium and Divalproex`on Brain-Derived Neurotrophic Factor in Huntington's Disease [clinicaltrials:NCT00095355]TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease [clinicaltrials:NCT00146211]Effects of Music Therapy on Huntington's Disease [clinicaltrials:NCT00178360]clinicaltrials:NCT00190450Safety and Tolerability Study of Phenylbutyrate in Huntington's Disease (PHEND-HD) [clinicaltrials:NCT00212316]Efficacy and Safety of Tetrabenazine in Chorea [clinicaltrials:NCT00219804]clinicaltrials:NCT00271596clinicaltrials:NCT00277355Riluzole in Huntington's Disease [clinicaltrials:NCT00277602]Cooperative Huntington's Observational Research Trial [clinicaltrials:NCT00313495]clinicaltrials:NCT00368849clinicaltrials:NCT00387270Research of Biomarkers in Parkinson Disease [clinicaltrials:NCT00465790]Individuals Patterns of Disclosure About Huntington s Disease (HD) and the Association With Adaptation to HD [clinicaltrials:NCT00491842]clinicaltrials:NCT00497159clinicaltrials:NCT00514774Making Sense of a Positive Genetic Test Result for Huntington Disease [clinicaltrials:NCT00539747]clinicaltrials:NCT00592995clinicaltrials:NCT00608881clinicaltrials:NCT00632645Study of Memantine to Treat Huntington's Disease [clinicaltrials:NCT00652457]Memory Disorders Registry [clinicaltrials:NCT00654563]A Study of Treatment With ACR16 in Patients With Huntington's Disease [clinicaltrials:NCT00665223]clinicaltrials:NCT00670709Far Infrared Irradiation for Managing, Control and Treatment of Huntington's Disease (HD) [clinicaltrials:NCT00675077]clinicaltrials:NCT00712426A Study of ACR16 for the Treatment of Patients With Huntington's Disease [clinicaltrials:NCT00724048]A Phase 1 Study To Evaluate The Effect Of Dimebon On The Pharmacokinetics Of Dextromethorphan [clinicaltrials:NCT00788047]A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function [clinicaltrials:NCT00824590]A Phase 1 Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF-01913539] In Japanese And Western Healthy Subjects [clinicaltrials:NCT00825084]A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF 01913539) On The Single-Dose Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects [clinicaltrials:NCT00827034]clinicaltrials:NCT00831506A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions [clinicaltrials:NCT00870974]
condition browse [clinicaltrials_vocabulary:condition-browse]
Treatment of Huntington's Chorea With Amantadine [clinicaltrials:NCT00001930]Long-Term Study of Cerebral Glucose Metabolism in Huntington's Disease [clinicaltrials:NCT00004753]Creatine Therapy for Huntington's Disease [clinicaltrials:NCT00026988]Minocycline in Patients With Huntington's Disease [clinicaltrials:NCT00029874]clinicaltrials:NCT00051324Prospective Huntington At Risk Observational Study [clinicaltrials:NCT00052143]Family Health After Predictive Huntington Disease (HD) Testing [clinicaltrials:NCT00075140]Effects of Lithium and Divalproex`on Brain-Derived Neurotrophic Factor in Huntington's Disease [clinicaltrials:NCT00095355]TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease [clinicaltrials:NCT00146211]Effects of Music Therapy on Huntington's Disease [clinicaltrials:NCT00178360]clinicaltrials:NCT00190450Safety and Tolerability Study of Phenylbutyrate in Huntington's Disease (PHEND-HD) [clinicaltrials:NCT00212316]Efficacy and Safety of Tetrabenazine in Chorea [clinicaltrials:NCT00219804]clinicaltrials:NCT00271596clinicaltrials:NCT00277355Riluzole in Huntington's Disease [clinicaltrials:NCT00277602]Cooperative Huntington's Observational Research Trial [clinicaltrials:NCT00313495]clinicaltrials:NCT00368849clinicaltrials:NCT00387270Research of Biomarkers in Parkinson Disease [clinicaltrials:NCT00465790]Individuals Patterns of Disclosure About Huntington s Disease (HD) and the Association With Adaptation to HD [clinicaltrials:NCT00491842]clinicaltrials:NCT00497159clinicaltrials:NCT00514774Making Sense of a Positive Genetic Test Result for Huntington Disease [clinicaltrials:NCT00539747]clinicaltrials:NCT00592995clinicaltrials:NCT00608881clinicaltrials:NCT00632645Study of Memantine to Treat Huntington's Disease [clinicaltrials:NCT00652457]Memory Disorders Registry [clinicaltrials:NCT00654563]A Study of Treatment With ACR16 in Patients With Huntington's Disease [clinicaltrials:NCT00665223]clinicaltrials:NCT00670709Far Infrared Irradiation for Managing, Control and Treatment of Huntington's Disease (HD) [clinicaltrials:NCT00675077]clinicaltrials:NCT00712426A Study of ACR16 for the Treatment of Patients With Huntington's Disease [clinicaltrials:NCT00724048]A Phase 1 Study To Evaluate The Effect Of Dimebon On The Pharmacokinetics Of Dextromethorphan [clinicaltrials:NCT00788047]A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function [clinicaltrials:NCT00824590]A Phase 1 Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF-01913539] In Japanese And Western Healthy Subjects [clinicaltrials:NCT00825084]A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF 01913539) On The Single-Dose Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects [clinicaltrials:NCT00827034]clinicaltrials:NCT00831506A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions [clinicaltrials:NCT00870974]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Huntington Disease [clinicaltrials_resource:2ecd31de9e351001768dac1759857e52]
Bio2RDF identifier
2ecd31de9e351001768dac1759857e52
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:2ecd31de9e351001768dac1759857e52
identifier
clinicaltrials_resource:2ecd31de9e351001768dac1759857e52
title
Huntington Disease
@en
type
label
Huntington Disease [clinicaltrials_resource:2ecd31de9e351001768dac1759857e52]
@en
Huntington Disease